Lenalidomide (Revlimid®, CC-5013) in Subjects With Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma

Clinical trial NCT00179673 · COMPLETED

Trial details

NCT number: NCT00179673
Sponsor: Celgene
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Non-Hodgkins Lymphoma

Start date: 2005-06-01
Primary completion: 2008-04-01
Enrollment: 43

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.